Author:
Huang Shang-Yi,Chang Cheng-Shyong,Tang Jih-Luh,Tien Hwei-Fang,Kuo Tsung-Li,Huang Shiu-Feng,Yao Yu-Tung,Chou Wen-Chien,Chung Chih-Yuan,Wang Chiu-Hwa,Shen Ming-Ching,Chen Yao-Chang
Reference12 articles.
1. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells;Chen;Blood,1997
2. Arsenical neuropathy;Chhuttani;Neurology,1967
3. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment;Chou;Leukemia,1997
4. All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia;Degos;Blood,1995
5. Dubowitz , V. Sewry , C.A. Fitzsimons , R.B. 1985 Muscle Biopsy: a Practical Approach 246 253
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献